INmune Bio (INMB) SEC Filings & 10K Form

$11.74
+0.45 (+3.99%)
(As of 01:56 PM ET)

Recent INmune Bio SEC Filings

DateFilerForm TypeView
04/26/2024
3:26 PM
INmune Bio (Filer)
Form 424B5
04/25/2024
3:35 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
1:07 PM
INmune Bio (Issuer)
Juda Scott (Reporting)
Form 4/A
04/24/2024
1:08 PM
INmune Bio (Issuer)
Lowdell Mark William (Reporting)
Form 4/A
04/24/2024
1:08 PM
INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
Form 4/A
04/24/2024
1:10 PM
INmune Bio (Issuer)
Moss David J (Reporting)
Form 4/A
04/23/2024
4:53 PM
INmune Bio (Issuer)
Juda Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
4:54 PM
INmune Bio (Issuer)
Lowdell Mark William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
4:54 PM
INmune Bio (Issuer)
Moss David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
4:55 PM
INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
4:09 PM
INmune Bio (Filer)
Form 424B5
04/22/2024
4:10 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
3:58 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:06 PM
INmune Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/30/2024
7:02 AM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
3:15 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
10:31 AM
INmune Bio (Issuer)
Juda Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
8:10 AM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
3:39 PM
INmune Bio (Filer)
Form 424B5
08/16/2023
3:41 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
5:02 AM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
3:05 PM
INmune Bio (Issuer)
Schroeder Timothy j (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:00 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
12:23 PM
CTI Holdings, Inc (Reporting)
INmune Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2023
7:00 AM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
7:02 AM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:INMB) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners